Ackman says supports Allergan's $66 billion sale to Actavis: CNBC

(Reuters) - Activist investor William Ackman is supporting the $66 billion deal in which Actavis PLC will buy Allergan Inc and plans to withdraw from an Allergan special shareholder meeting he had planned, CNBC television reported on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.